These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Some biological aspects of the aging brain. Terry RD Mech Ageing Dev; 1980; 14(1-2):191-201. PubMed ID: 7010009 [No Abstract] [Full Text] [Related]
5. Measurement of gamma-aminobutyric acid turnover rates in brain nuclei as an index of interactions between gamma-aminobutyric acid and other transmitters. Revuelta AV; Cheney DL; Costa E Adv Biochem Psychopharmacol; 1981; 27():169-81. PubMed ID: 6108692 [No Abstract] [Full Text] [Related]
6. Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain. Mesulam M; Guillozet A; Shaw P; Quinn B Neurobiol Dis; 2002 Feb; 9(1):88-93. PubMed ID: 11848688 [TBL] [Abstract][Full Text] [Related]
7. Acetylcholine at motor nerves: storage, release, and presynaptic modulation by autoreceptors and adrenoceptors. Wessler I Int Rev Neurobiol; 1992; 34():283-384. PubMed ID: 1587718 [No Abstract] [Full Text] [Related]
8. Future prospects of research on central cholinergic mechanisms. Nordberg A; Appel SH; Gottfries CG; Mesulam MM Prog Brain Res; 1990; 84():415-8. PubMed ID: 2267313 [No Abstract] [Full Text] [Related]
9. Functional pharmacology in human brain. Raiteri M Pharmacol Rev; 2006 Jun; 58(2):162-93. PubMed ID: 16714485 [TBL] [Abstract][Full Text] [Related]
10. [Central acetylcholinergic systems in the normal aged and in the patient with Alzheimer-type dementia (ATD)]. Ogawa N Rinsho Shinkeigaku; 1989 Dec; 29(12):1529-31. PubMed ID: 2698298 [TBL] [Abstract][Full Text] [Related]
11. Cholinergic markers in Alzheimer disease and the autoregulation of acetylcholine release. Quirion R J Psychiatry Neurosci; 1993 Nov; 18(5):226-34. PubMed ID: 8297921 [TBL] [Abstract][Full Text] [Related]
12. [Changes in the energy status of the brain structures in pharmacological exposures]. Arkhipov VI; Bulantsev AIu Farmakol Toksikol; 1986; 49(3):115-9. PubMed ID: 2873050 [No Abstract] [Full Text] [Related]
13. GABAergic function in Alzheimer's disease: evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia. Lanctôt KL; Herrmann N; Mazzotta P; Khan LR; Ingber N Can J Psychiatry; 2004 Jul; 49(7):439-53. PubMed ID: 15362248 [TBL] [Abstract][Full Text] [Related]
14. [Piracetam and the activity of alpha- and beta-adrenergic, dopaminergic and muscarine cholinergic receptors (author's transl)]. Atanacković D; Simonić A Lijec Vjesn; 1981 Dec; 103(12):545-9. PubMed ID: 6285100 [No Abstract] [Full Text] [Related]
15. [Executive function deficits in normal aging, Alzheimer's disease, and frontotemporal dementia]. Bherer L; Belleville S; Hudon C Psychol Neuropsychiatr Vieil; 2004 Sep; 2(3):181-9. PubMed ID: 15689332 [TBL] [Abstract][Full Text] [Related]
16. Effects of bright light on adrenergic and cholinergic systems. Majchrzak MJ; Dilsaver SC Am J Psychiatry; 1988 Dec; 145(12):1608. PubMed ID: 3195686 [No Abstract] [Full Text] [Related]
17. The brain cholinergic system in ageing mammals. Pepeu G; Casamenti F; Pepeu IM; Scali C J Reprod Fertil Suppl; 1993; 46():155-62. PubMed ID: 8315616 [TBL] [Abstract][Full Text] [Related]
18. Potential therapies in aging and senile dementias. Roberts E Ann N Y Acad Sci; 1982; 396():165-78. PubMed ID: 6960799 [No Abstract] [Full Text] [Related]
19. [Current concepts of the physiology of uteroplacental circulation]. Atanasov A; Kiutukchiev B; Ganchev S Akush Ginekol (Sofiia); 1985; 24(2):66-72. PubMed ID: 3893191 [No Abstract] [Full Text] [Related]